|Publication number||US8061006 B2|
|Application number||US 10/484,751|
|Publication date||Nov 22, 2011|
|Filing date||Jul 25, 2002|
|Priority date||Jul 26, 2001|
|Also published as||US20040255447, US20080300535|
|Publication number||10484751, 484751, PCT/2002/3395, PCT/GB/2/003395, PCT/GB/2/03395, PCT/GB/2002/003395, PCT/GB/2002/03395, PCT/GB2/003395, PCT/GB2/03395, PCT/GB2002/003395, PCT/GB2002/03395, PCT/GB2002003395, PCT/GB200203395, PCT/GB2003395, PCT/GB203395, US 8061006 B2, US 8061006B2, US-B2-8061006, US8061006 B2, US8061006B2|
|Inventors||Mark Anthony Fernance Kendall, Edward R. Smith, John Watson, Graham Ford|
|Original Assignee||Powderject Research Limited|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (154), Non-Patent Citations (3), Referenced by (6), Classifications (28), Legal Events (3)|
|External Links: USPTO, USPTO Assignment, Espacenet|
The present invention relates generally to the retention of particles prior to the needleless injection of those particles in a gas stream. More specifically, the present invention relates to particle cassettes having a pair of membranes which retain the particles in a chamber therebetween.
Needleless syringe devices are known from WO 94/24263. In this document, a needleless syringe is disclosed which entrains particles in a gas stream accelerated through a nozzle so that the particles may be injected into a target, such as human skin or other cells. For many applications, there is a need for the particles to be maintained in a sterile environment prior to actuation of the device. WO 94/24263 discloses for this purpose a particle cassette comprising a central annular ring having rupturable diaphragms sealed to each face so as to form a self contained sealed unit containing the particles to be injected. Upon actuation of the device, the diaphragms rupture allowing the particles initially contained between the diaphragms to be entrained in the gas flow and then delivered into the target.
An exemplary needleless syringe is shown in
WO 94/24263 discloses that the diaphragm should preferably be heat sealed to the faces of the annular ring. Heat sealing has been found to be a particularly easy and repeatable method of sealing the diaphragms to the ring of the cassette body.
It has been found that the above-mentioned configuration has a disadvantage associated with its manufacture, which may become especially deleterious when heat-sensitive particles (e.g. powdered drugs) are to be carried by the cassette. After the particles have been supplied to the chamber (11) formed by the annular ring (10) and the bottom membrane (12), the heat sealing of the top membrane (14) onto the ring (10) can sometimes result in a degradation of the particles. This degradation may take the form of melting, causing particle deformation, particle agglomeration and other undesirable physical and chemical changes in the product. Further, the melt may affect the therapeutic effect of the particles.
Accordingly, the present invention seeks to alleviate this problem by providing a particle cassette, a kit of parts and a method for the manufacture therefor in which the possibility of the particles melting during manufacture is much reduced.
In accordance with the first aspect of the present invention, there is provided a kit of parts for use in the manufacture of a particle cassette for a needleless syringe device, said kit comprising:
Thus, since the membranes are sealed to first and second cassette parts (possibly by heat sealing) before the particles are supplied to either of the cassette parts, there is a much reduced possibility of the membrane heat sealing process influencing the particle condition or composition. Further, the invention provides a quick and easy method of manufacturing a particle cassette and has these advantages over processes which do not involve heat sealing.
Preferably, the first and second cassette parts are annular such that the second part is attachable concentrically around or inside the first cassette part. This allows the first cassette part to extend substantially along the whole width of the particle cassette making it easier to fill the first part with particles prior to attaching the second part.
To attach the first and second parts together, a variety of mechanisms may be used, including interference fits, friction fits, screw fits, detents and recesses, close tolerances, gluing etc. A snap fit may be provided for by arranging corresponding features on each of the first and second parts (for example a detent and a recess).
In order to ensure a consistent width of particle cassette, it is preferable to provide a seating face on each of the first and second parts, such a seating face providing a minimum possible width of particle cassette when assembled.
A tapered face on each of the first and second parts allows the parts to be brought together easily during assembly.
A third cassette part may be used to attach the first and second parts together. In a preferred embodiment, the third cassette part is inserted in an annular apace between the first and second cassette parts, to provide a secure attachment (or “locling”). The third part preferably has a third membrane to ensure sterility and may be provided with one or more protrusions to ensure an interference fit with the second cassette part.
In a second aspect of the invention, there is provided a particle cassette for a needleless syringe comprising an assembled kit according to the first aspect and particles provided in the chamber between the first and second membranes.
According to a third aspect of the present invention, there is provided a needleless syringe including the particle cassette of the second aspect of the invention.
According to a fourth aspect of the invention, there is provided a method of assembling a particle cassette for a needleless syringe device, said method comprising:
The sealing of the membranes to the cassette parts independently from the steps of supplying particles to one of the cassette parts and attaching the cassette parts together ensures that the method used for sealing the membranes to the cassette parts does not unduly influence the quality of the particles in the cassette.
Preferably, attaching step (d) does not involve the application of any heat at all and it is preferably carried out at the same temperature as supplying step (c) to ensure that the particles are not affected by the step of attaching the first and second cassette parts together.
It is not essential that supplying step (c) is carried out after sealing step (b) since the second membrane may be sealed to the second cassette part after the particles have been supplied to the first cassette part.
Embodiments of the present invention will now be described, by way of example only, with reference to the accompanying schematic drawings, in which:
In the drawings the components are not drawn to scale. The drawings are schematic for reasons of clarity. In reality the thickness of the rupturable diaphragms may be much less than that shown and/or the volume of particles may be so small as barely to be visible to the naked eye.
The present invention avoids the possibility of the heat sealing of the membranes affecting the particle quality by ensuring that the particles are confined within the chamber of the cassette by a step other than one involving heat sealing of one of the membranes. Thus, generally speaking, each of the embodiments of the present invention comprises a first cassette part (20) having a first membrane (22) sealed to a face and a second cassette part (21) having a second membrane (23) sealed to a face. Particles (24) are dispensed into the first cassette part and the second cassette part is then attached. The attachment step should not involve the application of an amount of heat such as is likely to damage the particles. However, heat sealing can be used in the attachment step if the heat is used such that the particles are not likely to be damaged.
In the first embodiment, the first cassette part (20) comprises an annular ring having a first face (the upper face in
In order to manufacture the particle cassette, particles (24) are dispensed to the first cassette part (20) and the first (20) and second (21) cassette parts are attached together so as to create a closed chamber for the confinement of the particles (24) between the first (22) and second (23) membranes. The assembled particle cassette is shown in
In use, the particle cassette is located in a needleless syringe device which may have the general construction, and method of operation, described in WO 94/24263 or WO 01/05455, the contents of which are hereby incorporated by way of reference. When located in the syringe device the device construction is advantageously such as to prevent the first cassette part (20) coming away from the second cassette part (21). However, in order to mitigate against further such detachment, the second cassette part (21) may be adhered to the first cassette part (20), for example by gluing or by taping around the external circumference of the particle cassette. This provides a sealed unit of particles which can be handled outside of the needleless syringe device with reduced possibility of particles escaping from between the two cassette halves.
A second embodiment of the invention is shown in
In the second embodiment, the first cassette part (20) is constituted by a substantially annular member which extends to a height X nearly equal to the height Y of the assembled particle cassette. This greatly facilitates the filling of the first cassette part (21) with particles (24) since a larger receptacle than is provided in the first embodiment can be used to receive particles (24). A further advantage is that the whole internal volume of the cassette can be used to hold particles. In contrast, the first embodiment can only be half filled with particles since the first cassette part (20) has a height equivalent only to approximately half the final height of the cassette.
The second cassette part (21) also has a substantially annular construction and is arranged to be attachable concentrically around the first cassette part (20). If necessary, adhesive can be used at the interface (25) to ensure that the first and second cassette parts do not detatch easily. More preferred, however, is that the cassette parts are attached by an interference fit, whereby the outer diameter of the engaging region of the first cassette part is slightly larger than the inner diameter of the engaging region of the second cassette part (21). In this way, the parts will naturally lock together due to the elastic strain established in each of the first and second cassette parts when the second part (21) is placed around the first part (20).
The second embodiment shown above has advantages over the first embodiment because it does not necessarily require an extra adhesive to be used (an interference fit is instead used) and because the first cassette part defines a larger receptacle area for receiving the particles (24). However, the second embodiment has the disadvantage that it may be difficult or fiddly to assemble, even if one or both of the engaging inner face of the second cassette part and the engaging outer face of the first cassette part is provided with a lead in taper to aid assembly. To overcome this problem, a cassette according to the third embodiment of the invention is provided. Such a cassette is shown in
In the third embodiment of the present invention, the outer engaging face of the first cassette part (20) and the inner engaging face of the second cassette part (21) (the interface of which is denoted as (26) in
The third embodiment of the invention thus has the advantage that it is easier to assemble the kit of parts than the second embodiment of the invention. However, it has the potential disadvantage that the width of the cassette (ie the vertical dimension in
To overcome this problem, a particle cassette as shown in the fourth embodiment of the invention is provided.
In this embodiment, a seating face (27) is provided to each of the first (20) and second (21) cassette parts. As is shown in
While an interference fit is suitable for a lot of purposes, it is often preferable that no elastic strains are built up in the first and second cassette parts, especially if they are to be re-used a lot of times. The fifth embodiment of the invention addresses this problem.
The main difference is the provision on each of the first (20) and second (21) cassette parts of corresponding features (28, 29) which provide for a snap fit when the first and second cassette parts are brought together. In particular, the first cassette part (20) comprises a detent (28) located on one of external tapered surfaces (26). Correspondingly, the second cassette part (21) comprises a recess (29) on its respective tapered surface (26). Thus, when the first and second cassette parts are brought together, the detent (28) locates in the recess (29) to lock the two pieces together. During this attaching step, both the first and second cassette parts undergo a momentary elastic strain as the detent (28) engages in the recess (29) but, once assembled, the cassette part can be arranged so that there is little residual strain present. This means that there is no requirement to rely on an interference fit alone to maintain the first and second cassette parts in attachment. The provision of corresponding features also makes it more difficult for the first and second parts to be accidentally detached, providing a stronger lock between the first and second cassette parts and thus a more secure sealed environment for the particles. This is particularly useful when the cassette is to be subject to vibrations, such as those experienced during transportation. The fifth embodiment shown in
The fifth embodiment has a further advantage in that it provides an assembly that is tamper evident. Once assembled, it is very difficult to prise the cassette parts apart due to the taper lock and detent arrangement. Thus, the assembly could only be opened by destroying one of the membranes or using a very sharp tool to lever apart the parts, which in practice causes obvious deformation of the cassette parts.
Referring back to
The third cassette part (50), in common with the first and second cassette parts, has generally cylindrical inner and outer walls forming an annular-shaped member. One or more protrusions (51) may be formed on the outer walls and these are intended to provide an interference fit against the inner wall (34) of the second cassette part (30), when the particle cassette is assembled. The lower end of the third cassette part (50) has a number of formations (52) around the circumference. The formations (52) are stepped and are designed such that the top part (53) of the formations (52) abuts the top surface of the first cassette part (40) when assembled, as shown in
The particle cassette according to the sixth embodiment of the invention takes the form shown in
To assemble the particle cassette of the sixth embodiment, a first membrane (62) is heat sealed or bonded to the upper edge of the first cassette part (40). Similarly, the second membranes (63) is heat sealed or bonded to the seating face (32) of the second cassette part (30). The third membrane (61) is heat sealed or bonded to the upper face of the third cassette part (50). The first membrane and first cassette part thus define a receptacle in which the particles may be contained. The openings (43) are very small such that it is very difficult for the particles to pass out of the chamber once inside. Once the particles have been supplied to the chamber of the first cassette part (40), the first cassette part (40) is brought together with the second cassette part (30) with the leading edge of the first cassette part engaging the shoulders (31) of the second cassette part. The first cassette part (40) is pushed home until the seating face (41) of the first cassette part abuts the seating face (32) of the second cassette part (with the second membrane (63) between the two seating faces). In this configuration, the particles are trapped between the first and second membranes. The third cassette part (50) having the third membrane (61) thereon is then pushed in so that the formations (52) slide into the annular gap created between the first and second cassette parts. Interference and/or friction ensure that this movement firmly secures the first and second parts together and effectively “locks” the cassette. It will be appreciated that it is quite difficult to remove the third cassette part once it is installed, especially if the top face (55) of the third cassette part is dimensioned so as to be flush with the top face of the second cassette part when assembled (this is not shown in
The membrane (61) ensures that the particles inside the cassette may not come into contact with any external particles or gases and thus the membrane (61) ensures the sterility of the cassette.
In use, the cassette is inserted into a needleless syringe and gas pressure is supplied to the third membrane (61). The membrane (61) bursts quite easily and gas enters the internal space defined by the third cassette part. Gas is able to flow through the vents (54) and into the annular space (67) between the first cassette part and the second cassette part. From there, gas may pass through the transfer ducts and out through the openings (43) into the particle containment chamber. The jets of gas so formed cause the particles to be fluidized and mixed. Following that, the upstream membrane (62) bursts and the particles are entrained in the bulk of the gas flow followed by the bursting of the downstream membrane (63) shortly thereafter. In this way, the particle cassette of the sixth embodiment provides for pre-mixing and fluidizing of the particles whilst still overcoming the problem that heat sealing of membranes can damage particles when a single piece cassette is used.
The concepts described in relation to the first to fifth embodiments may also be applied to the sixth embodiment in the same way. For example, a snap fit may be provided for if detents and corresponding recesses are provided on either the first and second, first and third or second and third cassette parts respectively.
Heat sealing or adhesive is not necessary in the sixth embodiment and the first and second membranes may be sealed against the first and second cassette parts respectively due to the tight fit between the various cassette parts. For example, the first membrane (62) may be sealed by virtue of being trapped between the first and third cassette parts. Similarly, the second membrane (63) may be trapped between the first and second cassette parts, with no special heat sealing or adhesive step being required.
As can be seen from
To overcome this problem, a particle cassette as shown in the seventh and eighth embodiments of the invention is provided. The particle cassette itself has a built in expansion chamber (120) meaning that the syringe has less components overall. This results in a decrease in manufacturing time and complexity.
The seventh embodiment of the invention is shown in
It will also be apparent from
It can be seen that the particle cassette of the seventh embodiment retains the advantages of the previous embodiments in that the particles can be located in chamber (77) and the two cassette parts pressed together to confine the particles in a chamber, without the need to subject the particles to the heating that often accompanies sealing the membranes to the cassette parts. Furthermore, the seventh embodiment integrates part of the needleless syringe, viz, the expansion chamber (120), with the particle cassette, thereby reducing the number of components and the manufacturing time and expense.
An eighth embodiment of the invention is shown in
It will be apparent from both
The screw thread is preferably relatively coarse such that the first and second cassette parts can be connected together with relatively few turns. Preferably, less than one turn of relative movement is necessary, more preferably 180° or less of relative rotation. In the most preferred embodiment, a range of movement between 45° and 120°, preferably 90° is sufficient to attach the first and second cassette parts together.
Of course, the various means for attaching the cassette parts shown in the first to seventh embodiments may be combined with the features of the eighth embodiment, for example, seating faces, tapers and detents which provide a “snap-fit” can all be used in combination with the screw thread attachment. Furthermore, a third cassette part may be used in the seventh and eighth embodiments to lock the first and second cassette parts together.
It will be noted from
The screw thread design of the eighth embodiment has been found to give a more reproducible face seal between the mating surfaces of the first and second cassette part. This helps to prevents egress of payload from the chamber (87) inside the assembled cassette, and gives a more consistent barrier to potential biological contamination. Furthermore, the integration of the expansion chamber (120) with the particle cassette makes the overall dimensions of the cassette larger than in the prior art which facilitates handling and manipulation during manufacture of the needleless syringe comprising the cassette.
It is envisaged that other embodiments falling within the scope of the present claims can be provided by using combinations of the various attaching methods disclosed in the first to eighth embodiments herein. The type of attaching means to be used depends on the circumstances. For example, there are occasions when a “snap-fit” action is not suitable because the snapping provides a vibrational jolt to the cassette assembly which may damage particularly fragile particles. In such cases, an interference fit or screw fit is preferred.
For each of the embodiments, the materials used to manufacture the cassette parts and the membranes may be conventional, for example, the membranes may be Mylar as disclosed in WO 94/24263 and the first and second cassette parts are preferably manufactured from a plastics material, using injection moulding for example. Both the membranes and cassette parts may be made from polycarbonate such as Evaxone 260 (EVA) polymer. If heat sealing is used, a temperature of 110° C. and pressure of 760 kPa (110 psi) for 1.5 seconds has been found to be acceptable.
The cassette is suitable for any type of particle that one intends to deliver, including powdered drugs (therapeutics, medicaments, vaccines, anaesthetics, analgesics, and the like), diagnostic particles (whether inert or comprising an active ingredient), and carrier particles coated with peptides, proteins or genetic material.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US1300654||Jan 30, 1919||Apr 15, 1919||William H Rose||Dry-spraying machine.|
|US1434460 *||Feb 21, 1922||Nov 7, 1922||Tibbatts James||Metallic nursing bottle|
|US1774258||Jul 8, 1929||Aug 26, 1930||Raymond A English||Duplex capsule or the like|
|US1861047 *||May 13, 1929||May 31, 1932||Parke Davis & Co||Sealed capsule|
|US2147158||Sep 28, 1937||Feb 14, 1939||Philip Goldenthal||Powder insufflator|
|US2151418||May 12, 1937||Mar 21, 1939||Scott & Bowne||Powder applicator|
|US2307986||Feb 15, 1940||Jan 12, 1943||Bolte||Insufflator|
|US2314527 *||Jul 6, 1940||Mar 23, 1943||Atlantic Coast Fisheries Co||Method of making sealed capsules|
|US2470298||Feb 7, 1949||May 17, 1949||Abbott Lab||Powdered medicine dispenser|
|US2478715||Jul 14, 1948||Aug 9, 1949||Vilbiss Co||Powder blower|
|US2594093||Feb 5, 1949||Apr 22, 1952||Armour & Co||Powder container|
|US3216562||Jun 13, 1963||Nov 9, 1965||Driaire Inc||Easy-open capsule|
|US3324902 *||May 26, 1965||Jun 13, 1967||Bartelt Engineering Co Inc||Method of filling capsules|
|US3508677 *||Aug 20, 1968||Apr 28, 1970||Whittaker Corp||Vessel for storing high-pressure gases|
|US3659600 *||Feb 24, 1970||May 2, 1972||Charles River Foundation The||Magnetically operated capsule for administering drugs|
|US3664495 *||Dec 21, 1970||May 23, 1972||Parke Davis & Co||Locking capsule|
|US3674028||Jun 4, 1969||Jul 4, 1972||Ims Ltd||Multi-mix|
|US3735761 *||Feb 11, 1971||May 29, 1973||Ampoules Inc||Hypodermic devices|
|US3736933||Dec 2, 1970||Jun 5, 1973||Szabo B||Burstable seamed hypodermic applicators|
|US3782380||Jan 4, 1973||Jan 1, 1974||Gaast H V D||Medicament injecting device|
|US3788315||Apr 20, 1971||Jan 29, 1974||S Laurens||Disposable cutaneous transjector|
|US3797490 *||Aug 24, 1972||Mar 19, 1974||Ampoules Inc||Hypodermic ampoule with skin tensioning clip|
|US3797491 *||Aug 24, 1972||Mar 19, 1974||Ampoules Inc||Method of performing an intramuscular injection|
|US3810469 *||May 24, 1972||May 14, 1974||Ampoules Inc||Multiple compartment hypodermic devices|
|US3967761||Nov 4, 1974||Jul 6, 1976||Southwest Research Institute||System for injecting particulate material into the combustion chamber of a repetitive combustion coating apparatus|
|US4031892||Feb 13, 1976||Jun 28, 1977||Ampoules Corporation||Two-chamber mixing syringe|
|US4081077||Jan 13, 1977||Mar 28, 1978||Minnesota Mining And Manufacturing Company||Compartmented package|
|US4180173 *||Dec 13, 1977||Dec 25, 1979||Raychem Corporation||Tamper-proof closure system|
|US4226236||May 7, 1979||Oct 7, 1980||Abbott Laboratories||Prefilled, vented two-compartment syringe|
|US4360969 *||Sep 10, 1979||Nov 30, 1982||Bicc Limited||Chain of electrical connector housings and a method of fitting a housing to an electrical contact|
|US4362242 *||Mar 24, 1980||Dec 7, 1982||Cheetham J J||Multi-compartment container for storing and mixing dental amalgam ingredients, and method of using such a container|
|US4416370 *||Aug 25, 1982||Nov 22, 1983||Robert Beall||Compartmented container|
|US4474303 *||May 3, 1982||Oct 2, 1984||Maccise Adiv Y||Portable modular food container|
|US4515586||Nov 30, 1982||May 7, 1985||Abbott Laboratories||Powder syringe mixing system|
|US4517815 *||Oct 7, 1983||May 21, 1985||Basso Peter J||Insulated modular cooler|
|US4581875 *||Jun 20, 1983||Apr 15, 1986||Cosden Technology, Inc.||Process for forming tamper-resistant tamper-indicative capsules|
|US4596556||Mar 25, 1985||Jun 24, 1986||Bioject, Inc.||Hypodermic injection apparatus|
|US4627432||Oct 7, 1983||Dec 9, 1986||Glaxo Group Limited||Devices for administering medicaments to patients|
|US4703863 *||Aug 21, 1986||Nov 3, 1987||Kohusmariol Inc.||Baby feeding bottle assembly|
|US4738817 *||Sep 19, 1986||Apr 19, 1988||Warner-Lambert Company||Method for forming pharmaceutical capsules from hydrophilic polymers|
|US4774085||Jul 9, 1985||Sep 27, 1988||501 Board of Regents, Univ. of Texas||Pharmaceutical administration systems containing a mixture of immunomodulators|
|US4778054||Dec 1, 1986||Oct 18, 1988||Glaxo Group Limited||Pack for administering medicaments to patients|
|US4778068 *||Nov 24, 1987||Oct 18, 1988||Kohusmariol Inc.||Baby-feeding bottle|
|US4811731||Jul 29, 1986||Mar 14, 1989||Glaxo Group Limited||Devices for administering medicaments to patients|
|US4852757 *||Apr 21, 1988||Aug 1, 1989||Milton Gold||Adapter for expanding the volume of a container|
|US4858759||May 20, 1988||Aug 22, 1989||Hilti Aktiengesellschaft||Container arrangement for cartridge dispensing two-component mass|
|US4863017||Nov 9, 1988||Sep 5, 1989||Vlock D G||Amalgam capsule|
|US4893721 *||Nov 21, 1984||Jan 16, 1990||Warner-Lambert Company||Tamper-proof capsules|
|US4910866 *||Feb 21, 1989||Mar 27, 1990||Micron Technology, Inc.||Method of manufacturing a series of leadframe strip carriers having fixed external dimensions and varied internal dimensions using a common mold|
|US4939827 *||Sep 26, 1988||Jul 10, 1990||Diado Metal Company Ltd.||Method of manufacturing a bearing device including a housing with a flange at one end thereof and a bearing bush press-fitted thereinto|
|US4945050||Nov 13, 1984||Jul 31, 1990||Cornell Research Foundation, Inc.||Method for transporting substances into living cells and tissues and apparatus therefor|
|US4966581||Aug 5, 1988||Oct 30, 1990||Vitajet Industria E. Commercio Ltda||Non reusable disposable capsule containing an individual vaccine dose to be hypodermically injected with a pressure needleless injection apparatus|
|US4991377 *||Sep 18, 1989||Feb 12, 1991||Massimo Marchesini||Method for the mutual joining of the cap and the body of a capsule used to enclose medicines and apparatus which carries out this method|
|US5036006||Aug 17, 1989||Jul 30, 1991||Cornell Research Foundation, Inc.||Method for transporting substances into living cells and tissues and apparatus therefor|
|US5042472||Oct 15, 1990||Aug 27, 1991||Merck & Co., Inc.||Powder inhaler device|
|US5046618||Nov 19, 1990||Sep 10, 1991||R. P. Scherer Corporation||Child-resistant blister pack|
|US5053389||Apr 14, 1987||Oct 1, 1991||Per Balschmidt||Insulin preparation for non-parenteral administration|
|US5062830||Apr 4, 1990||Nov 5, 1991||Derata Corporation||Dry disposable nozzle assembly for medical jet injector|
|US5100792||Jan 24, 1989||Mar 31, 1992||Cornell Research Foundation, Inc.||Method for transporting substances into living cells and tissues|
|US5102388||Jul 15, 1991||Apr 7, 1992||Richmond John E||Sequential delivery syringe|
|US5120657||Oct 17, 1989||Jun 9, 1992||Agracetus, Inc.||Apparatus for genetic transformation|
|US5141496||Jan 27, 1992||Aug 25, 1992||Tino Dalto||Spring impelled syringe guide with skin penetration depth adjustment|
|US5149655||Jun 21, 1990||Sep 22, 1992||Agracetus, Inc.||Apparatus for genetic transformation|
|US5179022||Feb 11, 1992||Jan 12, 1993||E. I. Du Pont De Nemours & Co.||Biolistic apparatus for delivering substances into cells and tissues in a non-lethal manner|
|US5188615||Aug 7, 1991||Feb 23, 1993||Habley Medical Technology Corp.||Mixing vial|
|US5204253||May 29, 1990||Apr 20, 1993||E. I. Du Pont De Nemours And Company||Method and apparatus for introducing biological substances into living cells|
|US5207217||Jun 28, 1991||May 4, 1993||Promo Pack Sa||Multiple single-dose inhaler for medicaments in powder form|
|US5228573 *||Apr 23, 1991||Jul 20, 1993||Richard Pavelle||Pharmaceutical capsule and method of making|
|US5239991||May 19, 1992||Aug 31, 1993||Fisons Plc||Disposable powder medicament inhalation device with peel-off cover|
|US5256142||Jul 17, 1992||Oct 26, 1993||Sicim Spa||Injector administering subcutaneous injections without a needle and with a one-shot cap|
|US5349947||Jul 15, 1993||Sep 27, 1994||Newhouse Michael T||Dry powder inhaler and process that explosively discharges a dose of powder and gas from a soft plastic pillow|
|US5360410||Aug 6, 1991||Nov 1, 1994||Senetek Plc||Safety syringe for mixing two-component medicaments|
|US5371015||Jan 9, 1991||Dec 6, 1994||Cornell Research Foundation, Inc.||Apparatus for transporting substances into living cells and tissues|
|US5394980||Dec 23, 1993||Mar 7, 1995||Tsai; Min H.||Multicompartment mixing capsule|
|US5415162||Jan 18, 1994||May 16, 1995||Glaxo Inc.||Multi-dose dry powder inhalation device|
|US5422129 *||Apr 11, 1994||Jun 6, 1995||Draddy; John G.||Dispensing display container and particulate coffee therein|
|US5474195 *||Jan 24, 1995||Dec 12, 1995||Pai; Ming Y.||Built-up basket|
|US5478744||Aug 12, 1994||Dec 26, 1995||Cornell Research Foundation, Inc.||Method for transporting substances into living cells and tissues and apparatus therefor|
|US5492112||Apr 14, 1994||Feb 20, 1996||Dura Pharmaceuticals, Inc.||Dry powder inhaler|
|US5533505||Mar 3, 1993||Jul 9, 1996||Astra Aktiebolag||Disposable inhaler|
|US5560490||Sep 9, 1993||Oct 1, 1996||Fisons Plc||Pharmaceutical packaging with capsule sealing means|
|US5575281||Jul 13, 1995||Nov 19, 1996||Mecikalski; Mark B.||Medicated package|
|US5584807||Jan 20, 1995||Dec 17, 1996||Agracetus, Inc.||Gas driven gene delivery instrument|
|US5630796||Jun 7, 1995||May 20, 1997||Oxford Biosciences Limited||Method of delivering powder transdermally with needless injector|
|US5658892||Feb 7, 1995||Aug 19, 1997||The General Hospital Corporation||Compound delivery using high-pressure impulse transients|
|US5690249 *||Jul 6, 1995||Nov 25, 1997||Grona J Ab||Multi-sectioned improved air supply compost container|
|US5833089 *||Oct 2, 1992||Nov 10, 1998||Manni; Charles||Packaging for the extemporaneous preparation of drug products|
|US5865796||Dec 16, 1996||Feb 2, 1999||Powderject Vaccines, Inc||Gas driven gene delivery instrument|
|US5899880||Jun 7, 1995||May 4, 1999||Powderject Research Limited||Needleless syringe using supersonic gas flow for particle delivery|
|US5947928||Jun 19, 1997||Sep 7, 1999||Mile Creek Capital, Llc||Drug delivery system|
|US6003706 *||Sep 17, 1998||Dec 21, 1999||Polyfoam Packers Corporation||Adjustable depth insulated container|
|US6004286||Sep 18, 1998||Dec 21, 1999||Powderject Research Limited||Particle delivery|
|US6010478||Aug 14, 1997||Jan 4, 2000||Powderject Research Limited||Trans-mucosal particle delivery|
|US6013050||Apr 24, 1997||Jan 11, 2000||Powderject Research Limited||Particle delivery|
|US6165155 *||Jan 16, 1999||Dec 26, 2000||Sarcos, Lc||Multipathway electronically-controlled drug delivery system|
|US6168587||Dec 5, 1997||Jan 2, 2001||Powderject Research Limited||Needleless syringe using supersonic gas flow for particle delivery|
|US6276547 *||Jun 9, 2000||Aug 21, 2001||Thomas M. Petryna||Food containers with detachable and discardable sections|
|US6475181||Jul 3, 1998||Nov 5, 2002||Powderject Research Limited||Drug particle delivery|
|US6592545 *||Mar 15, 1999||Jul 15, 2003||Powderject Research Limited||Particle delivery|
|US6595352 *||Feb 20, 2001||Jul 22, 2003||Coltene Ag||Container for receiving a filling product and a method for its manufacture|
|US6685669 *||Dec 21, 1995||Feb 3, 2004||Powderject Research Limited||Particle delivery|
|US6881200 *||Feb 10, 1999||Apr 19, 2005||Powderject Research Limited||Needleless syringe using super sonic gas flow for particle delivery|
|US6923800 *||May 18, 2001||Aug 2, 2005||Alza Corporation||Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems|
|US6929005 *||Jun 12, 2001||Aug 16, 2005||Becton, Dickinson And Company||Medicament respiratory delivery device, cartridge and method of making same|
|US6949154 *||Jul 23, 2002||Sep 27, 2005||Boehringer Ingelheim Pharma Kg||Method and apparatus for sealing medicinal capsules|
|US6953039 *||Apr 8, 2003||Oct 11, 2005||Trudell Medical International||Medicament dispensing device|
|US6966899 *||Jul 31, 2002||Nov 22, 2005||Milestone Scientific, Inc.||Hand-piece for injection device with a retractable and rotating needle|
|US7014651 *||Jun 27, 2002||Mar 21, 2006||Alsius Corporation||Method and system for treating cardiac arrest using hypothermia|
|US7044134 *||Oct 19, 2001||May 16, 2006||Ev3 Sunnyvale, Inc||Method of implanting a device in the left atrial appendage|
|US7121402 *||Apr 1, 2004||Oct 17, 2006||Reactive Nano Technologies, Inc||Container hermetically sealed with crushable material and reactive multilayer material|
|US7562771||Jan 27, 2006||Jul 21, 2009||Lameplast S.P.A.||Bottle for two-component extemporaneous products|
|US7614496||Apr 8, 2006||Nov 10, 2009||Steven Dvorak||Aqueous solution of an analgesic and a dispenser therefor|
|US7618394 *||Dec 9, 2002||Nov 17, 2009||Powderject Research Limited||Needleless syringe using supersonic gas flow for particle delivery|
|US7691407 *||Dec 15, 2006||Apr 6, 2010||Smithkline Beecham Plc||Multi-component pharmaceutical dosage form|
|US7942846 *||Aug 31, 2007||May 17, 2011||Powderject Research Limited||Needleless syringe using supersonic gas flow for particle delivery|
|US20010015326 *||Feb 20, 2001||Aug 23, 2001||Coltene Ag||Container for receiving a filling product and a method for its manufacture|
|US20020091353 *||Sep 14, 2001||Jul 11, 2002||Bellhouse Brian John||Needleless syringe|
|US20030019558 *||Jul 26, 2001||Jan 30, 2003||Smith Edward R.||Particle cassette, method and kit therefor|
|US20040158197 *||Feb 2, 2004||Aug 12, 2004||Powderject Research Limited||Particle delivery|
|US20050010168 *||Jul 25, 2002||Jan 13, 2005||Kendall Mark Anthony Fernance||Silencing device and method for needleless syringe|
|US20060272963 *||Jul 17, 2006||Dec 7, 2006||Igal Sharon||Multi-compartment container assembly system|
|US20060289316 *||Jun 27, 2005||Dec 28, 2006||Henry John R||Mixing container|
|US20070185450 *||Feb 1, 2006||Aug 9, 2007||Marco De Polo||Self-sealing connection for housing shells of an administering device|
|US20090110723 *||Oct 15, 2008||Apr 30, 2009||Mcallister Stephen Mark||Linkers for multipart dosage forms for release of one or more pharmaceutical compositions, and the resulting dosage forms|
|US20100298767 *||Jun 4, 2007||Nov 25, 2010||Bates Nigel Robert||Particle Cassettes|
|USRE33801||Aug 15, 1988||Jan 21, 1992||Dentsply Research & Development Corp.||Mixing and discharge capsule|
|DE1047385B||Mar 8, 1952||Dec 24, 1958||Armour & Co||Puderzerstaeuber mit einem auswechselbaren Puderbehaelter|
|EP0313992A1||Oct 20, 1988||May 3, 1989||Alza Corporation||Plurality of tiny pills in liquid dosage form|
|EP0371838A1||Nov 3, 1989||Jun 6, 1990||Tino Dalto||Syringe guide with regulation of penetration depth into the skin|
|EP0406778A1||Jul 2, 1990||Jan 9, 1991||Erdélyi Dr. Dipl.-Ing. Gyula||Needleless inoculator|
|EP0458641A2||May 23, 1991||Nov 27, 1991||The Wellcome Foundation Limited||Use of prostaglandin derivatives in the treatment of congestive heart failure|
|EP0469814A1||Jul 29, 1991||Feb 5, 1992||Lilly Industries Limited||Medicament administering devices|
|EP0734737A2||Apr 8, 1994||Oct 2, 1996||Oxford BioSciences Limited||Particle delivery of particularly therapeutic powdered agents|
|EP0776224A1||Aug 17, 1995||Jun 4, 1997||PowderJect Research Limited||Particle delivery|
|EP0951917A2||Apr 8, 1994||Oct 27, 1999||PowderJect Research Limited||Particle delivery of particularly a powdered therapeutical agent|
|FR2360031A1||Title not available|
|GB501564A||Title not available|
|GB677523A||Title not available|
|GB2206794A||Title not available|
|JPS50101521A||Title not available|
|WO1991018991A1||Apr 29, 1991||Dec 12, 1991||E.I. Du Pont De Nemours And Company||Improved method and apparatus for introducing biological substances into living cells|
|WO1992004439A1||Aug 30, 1991||Mar 19, 1992||Brian John Bellhouse||Ballistic apparatus|
|WO1992010225A1||Dec 4, 1991||Jun 25, 1992||Medinject A/S||A two-compartment syringe assembly and a method of producing a two-compartment syringe assembly|
|WO1992012799A1||Jan 16, 1992||Aug 6, 1992||Dmw (Technology) Limited||Metered dose atomising and delivery device|
|WO1993003779A1||Aug 21, 1992||Mar 4, 1993||Weston Medical Limited||Needleless injector|
|WO1995019799A1||Jan 20, 1995||Jul 27, 1995||Agracetus, Inc.||Gas driven gene delivery instrument|
|WO1999001168A1||Jul 3, 1998||Jan 14, 1999||Powderject Research Limited||Drug particle delivery|
|WO1999001169A1||Jul 6, 1998||Jan 14, 1999||Powderject Research Limited||Syringe and capsule therefor|
|WO2000044421A1||Jan 27, 2000||Aug 3, 2000||Powderject Research Limited||Particle delivery device|
|WO2000062846A1||Apr 14, 2000||Oct 26, 2000||Powderject Research Limited||Needleless syringe|
|WO2001005455A1||Jun 9, 2000||Jan 25, 2001||Powderject Research Limited||Needleless syringe|
|WO2002007803A1||Jul 20, 2001||Jan 31, 2002||Powderject Research Limited||Needleless syringe|
|WO2002055139A1||Jan 11, 2002||Jul 18, 2002||Powderject Research Limited||Needleless syringe|
|WO2007141501A2 *||Jun 4, 2007||Dec 13, 2007||Powderject Research Limited||Improvements in, or relating to, particle cassettes|
|1||James H. Oard, et al, "Transient Gene Expression in Maize, Rice, and Wheat Cells Using an Airgun Apparatus", Plant Physiol (1990) 92, pp. 334-339.|
|2||R. Sanders Williams, et al, "Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles", Genetics (1991), pp. 2726-2730.|
|3||The Notice of References in the Corresponding U.S. Appl. No. 12/071,324, dated Dec. 27, 2010.|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US8298173 *||Jun 4, 2007||Oct 30, 2012||Bates Nigel Robert||Particle cassettes|
|US8540665||Nov 4, 2009||Sep 24, 2013||Powder Pharmaceuticals Inc.||Particle cassettes and processes therefor|
|US9044546||Aug 22, 2013||Jun 2, 2015||Powder Pharmaceuticals Incorporated||Particle cassettes and processes therefor|
|US9358338||Apr 28, 2015||Jun 7, 2016||Powder Pharmaceuticals Incorporated||Particle cassettes and processes therefor|
|US20100298767 *||Jun 4, 2007||Nov 25, 2010||Bates Nigel Robert||Particle Cassettes|
|USRE43824||Jan 11, 2002||Nov 20, 2012||Powder Pharmaceuticals Inc.||Needleless syringe|
|U.S. Classification||29/450, 29/469, 604/68, 206/571, 604/70, 29/458, 222/94, 29/453, 222/92, 29/525.01, 222/93, 29/463, 604/72, 222/107|
|International Classification||A61M5/30, A61M5/24, B23P11/02|
|Cooperative Classification||Y10T29/49893, Y10T29/4987, A61M5/2459, Y10T29/49885, Y10T29/49826, Y10T29/49947, A61M5/24, Y10T29/49904, A61M5/3015, Y10T29/49876|
|Oct 12, 2004||AS||Assignment|
Owner name: POWDERJECT RESEARCH LIMITED, GREAT BRITAIN
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KENDALL, MARK ANTHONY FERNANCE;SMITH, EDWARD R.;WATSON, JOHN;AND OTHERS;REEL/FRAME:015236/0994;SIGNING DATES FROM 20040212 TO 20040320
Owner name: POWDERJECT RESEARCH LIMITED, GREAT BRITAIN
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KENDALL, MARK ANTHONY FERNANCE;SMITH, EDWARD R.;WATSON, JOHN;AND OTHERS;SIGNING DATES FROM 20040212 TO 20040320;REEL/FRAME:015236/0994
|Apr 24, 2015||FPAY||Fee payment|
Year of fee payment: 4
|Mar 31, 2016||AS||Assignment|
Owner name: POWDER PHARMACEUTICALS INCORPORATED, HONG KONG
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:POWDERJECT RESEARCH LIMITED;REEL/FRAME:038165/0023
Effective date: 20160307